Cypress Capital Management LLC (Wy) Bristol Myers Squibb CO Transaction History

Cypress Capital Management LLC (Wy)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $28,228 - $33,468	-660 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $32,840 - $36,314	-736 Reduced 52.72%	660 $30,000
Q1 2019 May 06, 2019	SELL	$45.12 - $53.8 $7,399 - $8,823	-164 Reduced 10.51%	1,396 $67,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $17,066 - $22,130	-350 Reduced 18.32%	1,560 $81,000
Q3 2018 Oct 31, 2018	BUY	$55.19 - $62.25 $64,020 - $72,210	1,160 Added 154.67%	1,910 $119,000
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $12,632 - $15,745	-250 Reduced 25.0%	750 $42,000
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $20,972 - $24,143	-350 Reduced 25.93%	1,000 $63,000
Q4 2017 Jan 31, 2018	SELL	$59.94 - $65.35 $115,084 - $125,471	-1,920 Reduced 58.72%	1,350 $83,000
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $180,602 - $208,429	3,270	3,270 $208,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.